Sinovac Biotech Ltd., of Beijing, said it has been selected by the Beijing Health Bureau as the sole supplier of inactivated hepatitis A vaccine in pre-filled syringe dosage to the expanded program of immunization (EPI) for Beijing. The vaccines will be used for the period from 2014 to 2016, and the company expects to begin delivery in the coming months upon demand.